JAY ARTHUR: Open Payments
NPI 1083970040 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 101 payments from 15 companies in 2025. Trend: 2023 $1,727 · 2024 $1,287 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $487 |
| Lilly USA, LLC | 17 | $267 |
| Novartis Pharmaceuticals Corporation | 16 | $261 |
| GENZYME CORPORATION | 5 | $96 |
| Janssen Biotech, Inc. | 5 | $89 |
| UCB, Inc. | 4 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $75 |
| Amgen Inc. | 3 | $71 |
| Galderma Laboratories, L.P. | 3 | $50 |
| Incyte Corporation | 2 | $45 |
Products named: SKYRIZI, TALTZ, COSENTYX, RINVOQ, DUPIXENT, TREMFYA, Bimzelx, OTEZLA.
Industry payments across NE — which companies pay providers there.
